Pulmonary embolism (PE) is a complex and important clinical entity that requires accurate and timely diagnosis and management. With the advent of multidetector computed tomography (MDCT) technology, the ability to perform imaging for the detection of PE during the pulmonary arterial phase of contrast enhancement became a reality. The advancement of this technology over the last decade has led to ever-increasing utilisation of this imaging modality in the acute care setting.
Pulmonary embolism (PE) is a complex and important clinical entity that requires accurate and timely diagnosis and management. With the advent of multidetector computed tomography (MDCT) technology, the ability to perform imaging for the detection of PE during the pulmonary arterial phase of contrast enhancement became a reality. The advancement of this technology over the last decade has led to ever-increasing utilisation of this imaging modality in the acute care setting.
The relatively high frequency of negative MDCT examinations for PE at our facility led us to suspect that our clinical colleagues may not be screening the patient population with clinical algorithms as effectively as possible. This suspicion, coupled with an emergency medical department communication that suggested that the revised Wells criteria, published in 2006 in the Journal of Thrombosis and Thrombolysis, should be used for pre-MDCT screening led us to investigate whether pretest clinical algorithms were being applied at our institution [1e3] .
Current recommendations mandate that patients undergo D-dimer testing if there is a low pretest clinical probability of PE (Wells 4). A MDCT study or ventilation-perfusion lung scan should be pursued if the D-dimer result is positive, whereas a negative D-dimer result in this patient population has been shown to safely exclude PE [2e5] . Van Belle showed the 3 month incidence of PE in patients who had an unlikely Wells clinical probability score and negative D-dimer result to be 0.5% [5] . Patients with a high pretest probability of PE (Wells >4) should receive an MDCT or VQ scan, regardless of their D-dimer score [2e4].
Methods
Our project proposal was reviewed and approved by the University of Saskatchewan Bioethics in Human Research Committee and by our health region's review board. We performed a retrospective analysis of all of the MDCT PE studies performed at our institution between July 1, 2008, and December 31, 2008, that were found in the database of our Quadris radiology information system (Cerner Corporation, Kansas City, MO).
MDCTs for all patients were performed with an 8-detector CT scanner (Light Speed Ultra; GE Healthcare, Milwaukee, WI). The final case review and report generation for all MDCT PE studies at our institution, including studies initially interpreted by residents on call, were generated after case review with a supervising general radiologist. The resident and radiologist reached a consensus decision on the findings of the MDCT PE study. In the event of discordant interpretation of on-call studies by the oncall resident and the staff radiologist responsible for the report, it was standard practice at our institution for the radiology resident involved to inform the ordering physician(s) of any change in interpretation and to send a fax as a written addendum to the preliminary report that was included in the patient's chart. Study results were stratified into positive, indeterminate, and negative based on statements made in the generated report impression. If the report impression was qualified with statements such as ''this was a poor quality study'' or ''subsegmental arteries cannot be evaluated,'' then the study was considered indeterminate.
The laboratory health record of each of the 384 patients was reviewed to determine whether or not they had a VIDAS D-Dimer New automated enzyme-linked fluorescent assay (bioMérieux, Marcy L'Etoile, France) performed 1 week before their MDCT PE study. A D-dimer assay score of <500 mg/L was considered negative.
The charts of 171 of the 177 patients in whom a D-dimer test was not performed were reviewed to look for a documented Wells score or to calculate a score based on clinically provided information. Although other objective PE pretest probability clinical assessments (eg, the Geneva score), have been shown to be as effective as the Wells score [6] , the Wells score was used in the retrospective chart assessment because of its relative simplicity and the current recommendation for the use of this scoring system at our institution.
Because of poor specificity, D-dimer has been suggested as not being a cost-effective examination for inpatients more than 79 years old, those who sustained trauma, those who had recent surgery, or those with a stay of more than 3 days in the hospital [7e9] . Also, the D-dimer test may show falsenegative results in patients on anticoagulants [7] . Therefore, a MDCT PE study without a D-dimer measurement was considered to be the appropriate course of action in these patients. Up to 50% of D-dimer tests are negative in the 19th week of pregnancy, current recommendations remain that D-dimer testing should be performed in pregnant patients [4e8]. Collagen vascular disease was not considered to be a contraindication to D-dimer testing. The final assessment of each patient who had a MDCT PE examination resulted in the analysis of the MDCT PE radiologist report, patient demographics, documented pretest probability scores, and D-dimer test results. Results were analysed by using a c 2 test.
Results
A total of 384 MDCT PE studies were performed. Of these studies, 219 were for emergency patients, 23 were for outpatients, and 142 were for inpatients. We found that, in an attempt to improve the correct use of the D-dimer assay at our institution, since 2005, the Laboratory Medicine Department mandated that a Wells criteria pretest probability score sheet be filled out by all physicians who order D-dimer studies on emergency patients for the purpose of doing a workup for possible PE or deep venous thrombosis. When this sheet was filled out, a Wells probability score was documented in the patient's laboratory health record. This pretest probability score sheet stratifies patients into low, moderate, and high probability as illustrated in Table 1 [2] . This objective assessment has since been revised by Wells to stratify patients into unlikely and likely categories (Table 1) [3] .
Overall, there were 73 positive (19%), 22 indeterminate (6%), and 289 negative (75%) MDCT PE studies. Of this group of 384, 207 (54%) had a D-dimer test performed within 1 week before the MDCT PE examination (163 emergency patients, 5 outpatients, and 39 inpatients); of these patients, 30 had positive PE studies (14%). The percentage of positive studies stratified according to the age of the patients is listed in Table 2. A total of 170 patients had a Wells pretest clinical probability score documented in their laboratory records: 144 emergency patients, 24 inpatients and 2 outpatients. Thirtyseven patients (18 emergency patients, 16 inpatients, 3 outpatients) had a D-dimer test performed without a documented Wells pretest probability score in their laboratory record. These 37 charts were not reviewed to see if the D-dimer test was indicated. There was 88% compliance (144/163) among emergency physicians completing a Wells criteria pretest probability score sheet before ordering a D-dimer test.
We found that 177 of 384 patients (46%) did not have a D-dimer test performed, and, of these, 43 had positive PE studies (24%). The charts of 171 of these patients were reviewed to see if they may have benefited from a D-dimer test before the ordering of an MDCT PE study. Fifteen patients (4%) who did not have a D-dimer test performed, upon chart review, were found to be in the low pretest probability group and had no associated risk factors that could lead to a false-positive result. It is thought that these patients may have benefited from a D-dimer test before the MDCT PE study. Of these patients, 1 had a positive PE study. These findings are stratified according to patient status and are summarized in Table 3 .
The percentage of PE in those patients with a D-dimer test performed was 15% (30/207) and, therefore, significantly lower than in those without a D-dimer test (P ¼ .015). The greater percentage of positive studies among inpatients (23%) versus emergency patients (17%) was not statistically significant (P ¼ .14). Five of 207 patients (2%) had a MDCT PE study performed with a documented low-probability Wells score and negative D-dimer results and, according to current algorithms, should not have undergone a MDCT PE study. None of these patients had a positive PE study.
A total of 170 patients had a documented Wells score in their laboratory records; 54 of these patients (31%) had a D-dimer test performed despite having a Wells score higher than 4. Of this group, 13 of 54 (24%) had a positive MDCT PE examination. b Low probability, <2.0; moderate probability, 2.0e6.0; high probability, >6.0; PE unlikely, 4.0; PE likely, >4.0. These patients did not require a D-dimer test based upon the Wells criteria, and the cost of their laboratory assessment was unnecessary. The percentage of positive PE studies stratified according to pretest probabilities is summarized in Table 4 . The difference between the rate of positive PE studies in these 2 groups is not statistically significant (P ¼ .13).
Discussion
Despite our skeptical assessment of the screening processes for PE used by our clinical colleagues and our presumed low rate of positive MDCT PE examinations, we found that our clinical colleagues were using pretest screening processes for pulmonary thromboembolism. The clinicians were using pretest clinical algorithms that used the Wells algorithm scoring sheet before ordering the D-dimer laboratory test. The one shortcoming of the scoring strategy used was that it consisted of the original Wells criteria that stratifies patients into 3 diagnostic categories rather than the more universally accepted recently revised, scoring model with only 2 diagnostic categories (PE unlikely vs PE likely) [4] .
We acknowledge 2 short-comings of this study: (1) there was an overuse of the D-dimer test for patients who had a high-probability pre-MDCT Wells score, which raised the possibility of underutilisation of MDCT for PE for this patient population if the patient was found to have a negative D-dimer test, and (2) another variable not evaluated in this study was how many patients with a positive D-dimer test performed had a clinical condition or conditions that may have led to a false-positive result.
However, our primary concern when embarking on this project was that we seemed to be observing too many negative MDCT PE studies, which we surmised was because of the lack of appropriate pretest screening. This, we thought certain, was supported by the very low rate of positive MDCT PE examinations. This assumption was shown to be incorrect. Only 2% of patients who were stratified into the unlikely clinical category and had a negative D-dimer could have avoided a MDCT PE study. Further, only 4% of patients may have benefited from D-dimer testing, as noted on the chart review, before undergoing MDCT scanning, with a negative D-dimer result, thus potentially avoiding the ionizing radiation administered during the CT examination.
The prevalence of PE in those with an unlikely pretest clinical score and a positive D-dimer at our institution, 15.3%, is comparable to results published by Van Belle et al [5] , who found a PE prevalence of 23.2% in this population. The prevalence of PE in the clinically selected population of patients who had MDCT PE studies performed at our institution is quite high, 19%, in comparison with literature ranges of 2%e5% [10, 11] . The prevalence of PE in the noneD-dimer group was 24% in comparison with recent literature rates of 9% at other institutions [10] . Therefore, the clinicians at our institution are definitely applying pre-MDCT PE examinations clinical algorithms. The rate of a positive MDCT PE examination at our institution, rather than being too low, is actually quite high in comparison with the findings of other investigators. 
